publication date: Sep. 26, 2014


html Conversatoin.html

Pat White: NIH Funding “Our Only Concern”

A lobbying campaign will make an effort to secure an immediate, significant funding increase for NIH.

The effort, called ACT for NIH: Advancing Cures Today, seeks to bring together patients, scientists, advocates, and lawmakers on both sides of the aisle. Their objective is to demonstrate the impact of a decade of clamping down on NIH funding. Adjusted for inflation, NIH receives nearly 25 percent less funding than it did in 2003.

When appropriations were high, one in three research proposals was funded. Now, the success rate is one in six, the lowest in history. In some areas, the success rate is as low as one in ten.

The campaign is coordinated by Pat White, who recently left the position of associate director for legislative policy and analysis at NIH.

The advisory committee members are:

• David Baltimore, president emeritus of the California Institute of Technology,

• Ronald DePinho, president of MD Anderson Cancer Center,

• Jennifer Doudna, professor at the University of California, Berkeley,

• Bernadette Gray-Little, chancellor of the University of Kansas,

• Michael Milken, advocate for research innovation and public health,

• Ronald Petersen, director of the Mayo Alzheimer’s Disease Research Center and professor of neurology at the Mayo Clinic College of Medicine.

The ACT for NIH campaign is underwritten by Jed Manocherian, founder and chairman, who is a member of the MD … Continue reading 40-36 Conversation with The Cancer Letter

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.